Sutro Biopharma Statistics
Total Valuation
STRO has a market cap or net worth of $242.11 million. The enterprise value is -$43.89 million.
| Market Cap | 242.11M |
| Enterprise Value | -43.89M |
Important Dates
The next estimated earnings date is Thursday, August 8, 2024, after market close.
| Earnings Date | Aug 8, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
STRO has 81.79 million shares outstanding. The number of shares has increased by 4.66% in one year.
| Shares Outstanding | 81.79M |
| Shares Change (YoY) | +4.66% |
| Shares Change (QoQ) | +0.80% |
| Owned by Insiders (%) | 0.92% |
| Owned by Institutions (%) | 73.06% |
| Float | 60.39M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.57 |
| Forward PS | 4.78 |
| PB Ratio | 2.47 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.46, with a Debt / Equity ratio of 0.29.
| Current Ratio | 4.46 |
| Quick Ratio | 4.34 |
| Debt / Equity | 0.29 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -8.34 |
Financial Efficiency
Return on equity (ROE) is -89.30% and return on invested capital (ROIC) is -82.19%.
| Return on Equity (ROE) | -89.30% |
| Return on Assets (ROA) | -26.00% |
| Return on Capital (ROIC) | -82.19% |
| Revenue Per Employee | $513,550 |
| Profits Per Employee | -$383,187 |
| Employee Count | 300 |
| Asset Turnover | 0.35 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, STRO has paid $17.80 million in taxes.
| Income Tax | 17.80M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -36.75% in the last 52 weeks. The beta is 1.24, so STRO's price volatility has been higher than the market average.
| Beta (5Y) | 1.24 |
| 52-Week Price Change | -36.75% |
| 50-Day Moving Average | 3.77 |
| 200-Day Moving Average | 3.82 |
| Relative Strength Index (RSI) | 34.33 |
| Average Volume (20 Days) | 926,557 |
Short Selling Information
The latest short interest is 2.29 million, so 2.80% of the outstanding shares have been sold short.
| Short Interest | 2.29M |
| Short Previous Month | 1.90M |
| Short % of Shares Out | 2.80% |
| Short % of Float | 3.79% |
| Short Ratio (days to cover) | 2.96 |
Income Statement
In the last 12 months, STRO had revenue of $154.07 million and -$114.96 million in losses. Loss per share was -$1.88.
| Revenue | 154.07M |
| Gross Profit | 154.07M |
| Operating Income | -103.63M |
| Pretax Income | -97.16M |
| Net Income | -114.96M |
| EBITDA | -75.58M |
| EBIT | -86.75M |
| Loss Per Share | -$1.88 |
Balance Sheet
The company has $314.08 million in cash and $28.07 million in debt, giving a net cash position of $286.01 million or $3.50 per share.
| Cash & Cash Equivalents | 314.08M |
| Total Debt | 28.07M |
| Net Cash | 286.01M |
| Net Cash Per Share | $3.50 |
| Equity (Book Value) | 98.02M |
| Book Value Per Share | 1.20 |
| Working Capital | 275.07M |
Cash Flow
In the last 12 months, operating cash flow was -$115.37 million and capital expenditures -$3.82 million, giving a free cash flow of -$119.19 million.
| Operating Cash Flow | -115.37M |
| Capital Expenditures | -3.82M |
| Free Cash Flow | -119.19M |
| FCF Per Share | -$1.94 |
Margins
Gross margin is 100.00%, with operating and profit margins of -67.27% and -74.62%.
| Gross Margin | 100.00% |
| Operating Margin | -67.27% |
| Pretax Margin | -63.06% |
| Profit Margin | -74.62% |
| EBITDA Margin | -49.06% |
| EBIT Margin | -56.31% |
| FCF Margin | -77.36% |
Dividends & Yields
STRO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.66% |
| Shareholder Yield | -4.66% |
| Earnings Yield | -47.48% |
| FCF Yield | -49.23% |
Analyst Forecast
The average price target for STRO is $12.50, which is 322.30% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $12.50 |
| Price Target Difference | 322.30% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (5Y) | 15.70% |
| EPS Growth Forecast (5Y) | 11.44% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
STRO has an Altman Z-Score of -1.18 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.18 |
| Piotroski F-Score | 2 |